Illumina, Inc. (ILMN)-Product Pipeline Analysis, 2017 Update

Illumina, Inc. (ILMN)-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME3646PD
  • |
  • Pages: 54
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Illumina, Inc. (Illumina) provides sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company's portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company's products are distributed to various countries through its distributors in Africa, Asia Pacific, Central America, Europe, the Middle East, North America, and South America. Illumina is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Illumina, Inc.

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Illumina, Inc. Company Overview 6

Illumina, Inc. Company Snapshot 6

Illumina, Inc. Pipeline Products and Ongoing Clinical Trials Overview 6

Illumina, Inc.-Pipeline Analysis Overview 9

Business Description 9

Illumina, Inc.-Key Facts 10

Illumina, Inc.-Major Products and Services 11

Illumina, Inc. Pipeline Products by Development Stage 13

Illumina, Inc. Ongoing Clinical Trials by Trial Status 15

Illumina, Inc. Pipeline Products Overview 17

Albumin Multiplex Assay 17

Albumin Multiplex Assay Product Overview 17

Carboxyhemoglobin Levels Multiplex Assay 18

Carboxyhemoglobin Levels Multiplex Assay Product Overview 18

Companion Diagnostic Test-Oncology 19

Companion Diagnostic Test-Oncology Product Overview 19

InfiniumDx CytoSNP-12 Assay 20

InfiniumDx CytoSNP-12 Assay Product Overview 20

Lab-On-A-Chip 21

Lab-On-A-Chip Product Overview 21

LSD-100 Lysosomal Storage Enzyme Analyzer 22

LSD-100 Lysosomal Storage Enzyme Analyzer Product Overview 22

Molecular Diagnostic Test-HIV 23

Molecular Diagnostic Test-HIV Product Overview 23

MRSA Screening Test 24

MRSA Screening Test Product Overview 24

NGS Diagnostic System-Oncology 25

NGS Diagnostic System-Oncology Product Overview 25

NGS Diagnostic System-Reproductive Health 26

NGS Diagnostic System-Reproductive Health Product Overview 26

NGS-Based Companion Diagnostic Test-Metastatic Colorectal Cancer 27

NGS-Based Companion Diagnostic Test-Metastatic Colorectal Cancer Product Overview 27

NGS-Based Transplant Diagnostic Assay 28

NGS-Based Transplant Diagnostic Assay Product Overview 28

Pan-Cancer Screening Test 29

Pan-Cancer Screening Test Product Overview 29

Pan-Cancer Screening Test Clinical Trial 30

Portable Benchtop Analyzer-Viral Load Assay 31

Portable Benchtop Analyzer-Viral Load Assay Product Overview 31

STAT-Seq Test 32

STAT-Seq Test Product Overview 32

Total Serum Biliruibin Multiplex Assay 33

Total Serum Biliruibin Multiplex Assay Product Overview 33

Unbound Bilirubin Multiplex Assay 34

Unbound Bilirubin Multiplex Assay Product Overview 34

Verifi Prenatal Test 35

Verifi Prenatal Test Product Overview 35

Verifi Prenatal Test Clinical Trial 36

VeriSeq NIPT Analysis Software (48 Samples) 37

VeriSeq NIPT Analysis Software (48 Samples) Product Overview 37

Illumina, Inc.-Key Competitors 38

Illumina, Inc.-Key Employees 39

Illumina, Inc.-Key Employee Biographies 40

Illumina, Inc.-Locations And Subsidiaries 42

Head Office 42

Other Locations & Subsidiaries 42

Joint Venture 44

Recent Developments 45

Illumina, Inc., Recent Developments 45

Apr 10, 2017: CloudHealth Genomics Makes China's First Sequencing Data Available Using Illumina's NovaSeq 6000 45

Apr 10, 2017: Illumina Launches the VeriSeq NIPT Solution in Europe 45

Apr 03, 2017: Novogene Adds 25 Illumina NovaSeq Sequencers 45

Apr 03, 2017: Illumina Advances the Use of Genomics in Precision Oncology, Donates Thousands of Somatic Interpretations to CIViC 46

Feb 21, 2017: N-of-One dramatically speeds high-accuracy interpretation of the Illumina TruSight Tumor 170 Cancer Panel 46

Feb 20, 2017: Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina 47

Jan 31, 2017: Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016 47

Jan 30, 2017: Illumina Debuts VeriSeq Analysis Software (48 Samples), Optimized Data Analysis For Noninvasive Prenatal Testing 49

Jan 27, 2017: Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries 49

Jan 09, 2017: Illumina Introduces the NovaSeq Series-a New Architecture Designed to Usher in the $100 Genome 49

Appendix 51

Methodology 51

About GlobalData 53

Contact Us 53

Disclaimer 53

List of Figures

Illumina, Inc. Pipeline Products by Equipment Type 7

Illumina, Inc. Pipeline Products by Development Stage 13

Illumina, Inc. Ongoing Clinical Trials by Trial Status 15

List of Tables

Illumina, Inc. Pipeline Products and Ongoing Clinical Trials Overview 6

Illumina, Inc. Pipeline Products by Equipment Type 7

Illumina, Inc. Pipeline Products by Indication 8

Illumina, Inc. Ongoing Clinical Trials by Trial Status 8

Illumina, Inc., Key Facts 10

Illumina, Inc., Major Products and Services 11

Illumina, Inc. Number of Pipeline Products by Development Stage 13

Illumina, Inc. Pipeline Products Summary by Development Stage 14

Illumina, Inc. Ongoing Clinical Trials by Trial Status 15

Illumina, Inc. Ongoing Clinical Trials Summary 16

Albumin Multiplex Assay-Product Status 17

Albumin Multiplex Assay-Product Description 17

Carboxyhemoglobin Levels Multiplex Assay-Product Status 18

Carboxyhemoglobin Levels Multiplex Assay-Product Description 18

Companion Diagnostic Test-Oncology-Product Status 19

Companion Diagnostic Test-Oncology-Product Description 19

InfiniumDx CytoSNP-12 Assay-Product Status 20

InfiniumDx CytoSNP-12 Assay-Product Description 20

Lab-On-A-Chip-Product Status 21

Lab-On-A-Chip-Product Description 21

LSD-100 Lysosomal Storage Enzyme Analyzer-Product Status 22

LSD-100 Lysosomal Storage Enzyme Analyzer-Product Description 22

Molecular Diagnostic Test-HIV-Product Status 23

Molecular Diagnostic Test-HIV-Product Description 23

MRSA Screening Test-Product Status 24

MRSA Screening Test-Product Description 24

NGS Diagnostic System-Oncology-Product Status 25

NGS Diagnostic System-Oncology-Product Description 25

NGS Diagnostic System-Reproductive Health-Product Status 26

NGS Diagnostic System-Reproductive Health-Product Description 26

NGS-Based Companion Diagnostic Test-Metastatic Colorectal Cancer-Product Status 27

NGS-Based Companion Diagnostic Test-Metastatic Colorectal Cancer-Product Description 27

NGS-Based Transplant Diagnostic Assay-Product Status 28

NGS-Based Transplant Diagnostic Assay-Product Description 28

Pan-Cancer Screening Test-Product Status 29

Pan-Cancer Screening Test-Product Description 29

Pan-Cancer Screening Test-The Circulating Cell-free Genome Atlas Study 30

Portable Benchtop Analyzer-Viral Load Assay-Product Status 31

Portable Benchtop Analyzer-Viral Load Assay-Product Description 31

STAT-Seq Test-Product Status 32

STAT-Seq Test-Product Description 32

Total Serum Biliruibin Multiplex Assay-Product Status 33

Total Serum Biliruibin Multiplex Assay-Product Description 33

Unbound Bilirubin Multiplex Assay-Product Status 34

Unbound Bilirubin Multiplex Assay-Product Description 34

Verifi Prenatal Test-Product Status 35

Verifi Prenatal Test-Product Description 35

Verifi Prenatal Test-Prospective, Multi-center, Randomized Controlled Trial Comparing Pregnancy Outcomes Following Selection and Single Embryo Transfer (SET) Based on Preimplantation Genetic Screening (PGS) by Next Generation Sequencing (NGS) Versus Standard Morphological Assessment 36

VeriSeq NIPT Analysis Software (48 Samples)-Product Status 37

VeriSeq NIPT Analysis Software (48 Samples)-Product Description 37

Illumina, Inc., Key Employees 39

Illumina, Inc., Key Employee Biographies 40

Illumina, Inc., Other Locations 42

Illumina, Inc., Subsidiaries 42

Illumina, Inc., Joint Venture 44

Glossary 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Illumina, Inc., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 48195
Site License
USD 1500 INR 96390
Corporate User License
USD 2250 INR 144585

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com